Form 144/A Roivant Sciences Ltd. Filed by: Gline Matthew
Tweet
Share
E-mailATTACHMENTS / EXHIBITS
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Fibocom Achieves 4Gb LPDDR4x Memory Optimization on FG550, Strengthening Cost and Supply Competitiveness for 5G Devices
- Press Release: Sanofi’s Cenrifki (tolebrutinib) approved in the EU as the first disability-targeting medicine for secondary progressive multiple sclerosis without relapses
- Yotta Data Services Receives Frost & Sullivan's 2026 Indian Company of the Year Recognition for Leadership in Sovereign AI Infrastructure
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
